The recognition highlights our continued growth, innovation, and commitment to excellence in Pharmacovigilance Industry. Being part of the Forbes India Select 200 – DGEMS 2024, is a testament to the hard work and dedication of our incredible team. It reflects our relentless pursuit of core values like customer satisfaction, cutting-edge technology, affordability, agility, sustainability, etc. […]
Vitrana adds another Milestone to its ongoing successful implementation of TransformPV with one of the largest pharmaceutical organisation “Live” with TransformPV for meeting FDA eMDR requirement. The organization has implemented Vitrana’s TransformPV solution to meet its R3 eMDR regulatory requirements…
Vitrana uses cookies to to analyse our traffic and to personalise the content. We also disclose information about your use of our site with our analytics partners. Additional details are available in our cookie policy.